Skandinaviska Enskilda Banken (SEB)’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,500
Closed -$106K 1076
2021
Q2
$106K Hold
2,500
﹤0.01% 983
2021
Q1
$94K Buy
+2,500
New +$78.2K ﹤0.01% 1052
2018
Q1
Sell
-206,700
Closed -$3.9M 720
2017
Q4
$3.9M Sell
206,700
-1,392,900
-87% -$30.9M 0.03% 322
2017
Q3
$46.7M Buy
+1,599,600
New +$47.2M 0.42% 57

Other funds holding ACH

Skandinaviska Enskilda Banken (SEB)'s ACH Position: Q3 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Accendra Health (ACH) in Q3 2021, closing a stake of 2,500 shares — an estimated $106K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ACH in Q3 2017 and held it in 4 quarters. The position peaked at $46.7M in Q3 2017. 247 funds tracked by Wall St. Rank hold ACH as of Q3 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Accendra Health position as of Q3 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 2,500 Accendra Health shares in Q3 2021, an estimated $106K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Accendra Health in Q3 2017 and held it in 4 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Accendra Health position peaked at $46.7M in Q3 2017.
  • 247 funds tracked by Wall St. Rank held Accendra Health as of Q3 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2021, filed 10 Nov 2021.